HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00

Nyxoah (NASDAQ:NYXH) had its price target decreased by stock analysts at HC Wainwright from $17.00 to $15.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would indicate a potential upside of 87.50% from the company’s previous close.

Separately, Stifel Nicolaus dropped their price target on Nyxoah from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, March 14th.

Nyxoah Stock Down 10.2 %

NYXH opened at $8.00 on Wednesday. The firm has a market cap of $272.48 million, a price-to-earnings ratio of -4.28 and a beta of 1.42. The company has a debt-to-equity ratio of 0.21, a quick ratio of 4.95 and a current ratio of 5.28. The firm’s 50-day simple moving average is $10.42 and its 200-day simple moving average is $9.34. Nyxoah has a twelve month low of $6.76 and a twelve month high of $13.67.

Nyxoah (NASDAQ:NYXH) last issued its quarterly earnings data on Thursday, March 13th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03). Nyxoah had a negative return on equity of 51.68% and a negative net margin of 1,043.93%. The firm had revenue of $1.35 million for the quarter, compared to the consensus estimate of $2.02 million. Equities research analysts anticipate that Nyxoah will post -1.91 EPS for the current fiscal year.

Hedge Funds Weigh In On Nyxoah

Large investors have recently modified their holdings of the stock. Kovack Advisors Inc. raised its position in Nyxoah by 100.0% in the 4th quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock worth $160,000 after purchasing an additional 10,000 shares during the last quarter. Ameriprise Financial Inc. acquired a new stake in shares of Nyxoah in the 4th quarter valued at $135,000. Vestal Point Capital LP bought a new stake in shares of Nyxoah during the fourth quarter worth $23,394,000. Renaissance Technologies LLC acquired a new position in shares of Nyxoah during the fourth quarter valued at $187,000. Finally, Geode Capital Management LLC boosted its holdings in Nyxoah by 19.4% in the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after acquiring an additional 2,774 shares during the last quarter.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.